488 related articles for article (PubMed ID: 16042643)
1. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
Longshore D; Annon J; Anglin MD; Rawson RA
Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
[TBL] [Abstract][Full Text] [Related]
2. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
Anglin MD; Conner BT; Annon J; Longshore D
Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
[TBL] [Abstract][Full Text] [Related]
3. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
Blaine JD
NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
[TBL] [Abstract][Full Text] [Related]
4. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
[TBL] [Abstract][Full Text] [Related]
5. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
[TBL] [Abstract][Full Text] [Related]
6. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
Prendergast ML; Grella C; Perry SM; Anglin MD
J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
[TBL] [Abstract][Full Text] [Related]
7. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.
Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M
Addiction; 2003 Nov; 98(11):1605-13. PubMed ID: 14616187
[TBL] [Abstract][Full Text] [Related]
9. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts.
Freedman RR; Czertko G
Drug Alcohol Depend; 1981 Nov; 8(3):215-22. PubMed ID: 7327086
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
Newcombe DA; Bochner F; White JM; Somogyi AA
Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
[TBL] [Abstract][Full Text] [Related]
11. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
Patricio LD; Miguel N
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
[No Abstract] [Full Text] [Related]
12. LAAM maintenance vs methadone maintenance for heroin dependence.
Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W
Cochrane Database Syst Rev; 2002; (2):CD002210. PubMed ID: 12076441
[TBL] [Abstract][Full Text] [Related]
13. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
[TBL] [Abstract][Full Text] [Related]
14. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
Valdivia JF; Khattak S
Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
[TBL] [Abstract][Full Text] [Related]
15. Predictors of retention in methadone programs: a signal detection analysis.
Villafranca SW; McKellar JD; Trafton JA; Humphreys K
Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Stimmel B
J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
[No Abstract] [Full Text] [Related]
17. Comments on Ritter et al.'s report of a comparative trial of LAAM and methadone maintenance.
Caplehorn J
Addiction; 2004 Apr; 99(4):509-10; author reply 510-1. PubMed ID: 15049750
[No Abstract] [Full Text] [Related]
18. Relationship between LAAM-methadone preference and treatment outcomes.
White JM; Danz C; Kneebone J; La Vincente SF; Newcombe DA; Ali RL
Drug Alcohol Depend; 2002 May; 66(3):295-301. PubMed ID: 12062464
[TBL] [Abstract][Full Text] [Related]
19. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats.
Newman JL; Vann RE; May EL; Beardsley PM
Psychopharmacology (Berl); 2002 Oct; 164(1):108-14. PubMed ID: 12373424
[TBL] [Abstract][Full Text] [Related]
20. Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial.
Wieneke H; Conrads H; Wolstein J; Breuckmann F; Gastpar M; Erbel R; Scherbaum N
Eur J Med Res; 2009 Jan; 14(1):7-12. PubMed ID: 19258204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
